Cherry SE header image

Cherry SE

C3RY

Equity

ISIN DE000A3CRRN9 / Valor 112129002

Xetra (2024-11-22)
EUR 0.64-3.31%

Cherry SE
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Cherry SE is a well-established manufacturer known for producing high-end mechanical keyboard switches and computer input devices for a variety of applications including gaming, e-sports, office, industry, and healthcare. With a history dating back to 1953, Cherry has built a reputation for delivering innovative and high-quality products tailored to meet the diverse needs of its customers.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (07.08.2024):

Revenue Growth

Cherry SE reported group revenue of EUR 61.6 million for the first half of 2024, marking a 0.4% increase compared to the same period in the previous year. This growth was primarily driven by the DIGITAL HEALTH & SOLUTIONS segment, which saw revenue growth of over 60%.

Adjusted EBITDA Margin

The adjusted EBITDA margin for Cherry SE in the first half of 2024 was 4.0%. This is a decrease from the 5.2% margin recorded in the same period of the previous year. The DIGITAL HEALTH & SOLUTIONS segment was a significant contributor to this positive development.

Inventory Levels

As of June 30, 2024, Cherry SE's inventory stood at EUR 59 million. This is seasonally higher than the EUR 55 million at the end of the first quarter but significantly lower than the EUR 80 million recorded on June 30, 2023.

Equity Ratio

Cherry SE's equity ratio improved to 56% as of the end of the first half of 2024, compared to 51% at the end of 2023. This indicates a stronger financial position for the company.

2024 Forecast Confirmation

Cherry SE has confirmed its forecast for the full year 2024, expecting group revenue between EUR 140 – 150 million and an adjusted EBITDA margin of 7 – 8%. The company also maintains its third-quarter forecast, anticipating group revenue of approximately EUR 35 million and an adjusted EBITDA margin in the range of 5% - 6%.

Summarized from source with an LLMView Source

Key figures

-77.8%1Y
-97.8%3Y
%5Y

Performance

82.9%1Y
67.5%3Y
65.6%5Y

Volatility

Market cap

17 M

Market cap (USD)

Daily traded volume (Shares)

1,040

Daily traded volume (Shares)

1 day high/low

0.665 / 0.63

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

monday.com Ltd.
monday.com Ltd. monday.com Ltd. Valor: 111719549
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.02%USD 284.59
Sakura Internet KK
Sakura Internet KK Sakura Internet KK Valor: 2269129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.89%JPY 4,475.00
KK QPS Kenkyusho
KK QPS Kenkyusho KK QPS Kenkyusho Valor: 130606762
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.13%JPY 1,565.00
Q2 Holdings Inc
Q2 Holdings Inc Q2 Holdings Inc Valor: 23733115
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.46%USD 104.95
ODDITY Tech Ltd.
ODDITY Tech Ltd. ODDITY Tech Ltd. Valor: 128034307
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.66%USD 45.56
Sinfonia Technology KK
Sinfonia Technology KK Sinfonia Technology KK Valor: 763277
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.44%JPY 5,810.00
Astera Labs Inc
Astera Labs Inc Astera Labs Inc Valor: 133211877
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.77%USD 102.28
Adverum Biotechnologies Inc
Adverum Biotechnologies Inc Adverum Biotechnologies Inc Valor: 133481885
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.04%USD 6.04
Cartesian Therapeutics Inc
Cartesian Therapeutics Inc Cartesian Therapeutics Inc Valor: 134256445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
13.54%USD 18.87
Ibotta Inc
Ibotta Inc Ibotta Inc Valor: 134027723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.72%USD 67.70